BrainsWay is a neurotechnology company specializing in advanced neuromodulation systems based on deep transcranial magnetic stimulation (Deep TMS). The company develops proprietary H-coil technology designed to stimulate deeper and broader brain regions compared with conventional TMS approaches.

BrainsWay’s systems deliver targeted electromagnetic stimulation protocols that have been clinically validated across multiple indications, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction. The company combines hardware, treatment protocols, and clinical software to support standardized delivery in regulated healthcare settings.

BrainsWay’s devices are deployed globally in hospitals and mental health clinics as prescription medical devices. The company positions its technology as a clinically established neuromodulation platform with expanding indications rather than an experimental or consumer-oriented brain stimulation approach.